Pfizer and Allergan Advisers Lose Out on $200 Million in Fees. Banking and Financial Institutions, Mergers, Acquisitions and Divestitures, Antitrust Laws and Competition Issues, Regulation and Deregulation of Industry, ALLERGAN INC, Pfizer Inc, Halliburton Company, Baker Hughes Inc